Detalles de la búsqueda
1.
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial.
Am J Hematol;
99(5): 836-843, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38400519
2.
Outcomes of toxoplasmosis after allogeneic hematopoietic stem cell transplantation and the role of antimicrobial prophylaxis.
Bone Marrow Transplant;
59(5): 699-704, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38355908
3.
Clinical relevance of MYC/BCL2 expression and cell of origin in patients with diffuse large b-cell lymphoma treated with autologous transplant.
Bone Marrow Transplant;
58(9): 1000-1007, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37198234
4.
The outcomes of patients with chronic myeloid leukemia treated with third-line BCR::ABL1 tyrosine kinase inhibitors.
Am J Hematol;
98(4): 658-665, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36683287
5.
Clinical outcome of allogeneic stem cell transplantation in patients with B-cell lymphoid malignancies following treatment with targeted small molecule inhibitors.
Leuk Lymphoma;
63(4): 885-893, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35225133
6.
Allogeneic hematopoietic cell transplantation for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN).
Bone Marrow Transplant;
57(1): 51-56, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34629467
7.
Nine-Year Follow-up of Patients with Relapsed Follicular Lymphoma after Nonmyeloablative Allogeneic Stem Cell Transplant and Autologous Transplant.
Clin Cancer Res;
27(21): 5847-5856, 2021 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34380640
8.
Hyper-CVAD plus ofatumumab versus hyper-CVAD plus rituximab as frontline therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: A propensity score analysis.
Cancer;
127(18): 3381-3389, 2021 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34138471
9.
Prognostic factors for progression in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia in complete molecular response within 3 months of therapy with tyrosine kinase inhibitors.
Cancer;
127(15): 2648-2656, 2021 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33793964
10.
Long-term follow-up of salvage therapy using a combination of inotuzumab ozogamicin and mini-hyper-CVD with or without blinatumomab in relapsed/refractory Philadelphia chromosome-negative acute lymphoblastic leukemia.
Cancer;
127(12): 2025-2038, 2021 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33740268
11.
Randomized phase II trial of extracorporeal phototherapy and steroids vs. steroids alone for newly diagnosed acute GVHD.
Bone Marrow Transplant;
56(6): 1316-1324, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33398094
12.
Impact of graft composition on outcomes of haploidentical bone marrow stem cell transplantation.
Haematologica;
106(1): 269-274, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32107328
13.
Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia.
Acta Haematol;
144(1): 74-81, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-32604096
14.
Busulfan and melphalan conditioning is superior to melphalan alone in autologous stem cell transplantation for high-risk MM.
Blood Adv;
4(19): 4834-4837, 2020 10 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33027527
15.
Idiopathic refractory ascites after allogeneic stem cell transplantation: a previously unrecognized entity.
Blood Adv;
4(7): 1296-1306, 2020 04 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-32236526
16.
Outcome of Multiple Myeloma with Chromosome 1q Gain and 1p Deletion after Autologous Hematopoietic Stem Cell Transplantation: Propensity Score Matched Analysis.
Biol Blood Marrow Transplant;
26(4): 665-671, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31881283
17.
Age Is a Prognostic Factor for the Overall Survival of Patients with Multiple Myeloma Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant;
26(6): 1077-1083, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31786242
18.
Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis.
Clin Cancer Res;
25(22): 6781-6787, 2019 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31481508
19.
Allogeneic Transplantation after Myeloablative Rituximab/BEAM ± Bortezomib for Patients with Relapsed/Refractory Lymphoid Malignancies: 5-Year Follow-Up Results.
Biol Blood Marrow Transplant;
25(7): 1347-1354, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30826465
20.
Impact of Donor Type and Melphalan Dose on Allogeneic Transplantation Outcomes for Patients with Lymphoma.
Biol Blood Marrow Transplant;
25(7): 1340-1346, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30763728